Advertise here
Advertise here

One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment

, 2025-05-07 20:20:00 Credit: Pixabay/CC0 Public Domain Presented at ESTRO 2025 in Vienna, Austria, a 10-year study involving over 4,000 UK patients confirms that a one-week course of post-surgery radiotherapy is just as safe and effective as the traditional three-week regimen for early-stage breast cancer patients. These long-term results from the FAST-Forward trial could further…

Read More

LSD for Anxiety and Depression: Worth the Trip?

, 2025-05-07 12:15:00 A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and Europe of MM120 (lysergide d-tartrate) for the treatment of generalized anxiety disorder (GAD) and major depressive disorder (MDD). The…

Read More

Robotic surgery upskilling in Korea, India and more briefs

, 2025-05-08 04:13:00 Intuitive Surgical signs investment, workforce training in Korea, India Intuitive Surgical, a developer of robotic surgical systems based in the United States, has signed deals in South Korea and India to help upskill healthcare professionals.   Under its memorandum of understanding with the government of Seoul, capital city of South Korea, it will…

Read More

A letter to my future physician self

Kayla R. Vaccaro , 2025-05-07 15:01:00 Dear future me (aka Dr. Probably Still Running on 4 Hours of Sleep, DO) … Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . ” data-action=subscribe> Subscribe We…

Read More

Marea, Novo, Inductive Bio, Met Gala

Elaine Chen , 2025-05-07 13:28:00 Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Biotech was not faring well yesterday, after we got the news that Vinay Prasad was chosen to be the next director of the FDA’s biologics center. We’ll get…

Read More

New guidelines on the role of emerging therapies in managing adults with metastatic brain tumors

, 2025-05-07 20:30:00 Credit: Anna Shvets from Pexels The Congress of Neurological Surgeons (CNS) has updated its guidelines on using emerging therapies to treat metastatic brain tumors, reflecting improvements in pharmaceuticals, radiation therapy software and hardware, and surgical equipment. Jeffrey J. Olson, MD, of the Department of Neurosurgery at Emory University School of Medicine in…

Read More

Study shows no connection between PM2.5 spikes and major cardiovascular events

, 2025-05-08 03:55:00 Despite concerns over air pollution spikes, this decades-long Danish study finds that repeated PM2.5 peaks are not linked to increased cardiovascular risk, highlighting the greater importance of chronic exposure. The role of long-term PM2.5 peaks in cardiovascular risk: an AIRCARD substudy. Image Credit: winnond / Shutterstock In a recent study published in the Journal of…

Read More

Anticoagulation in Subclinical AF May Offer Little Benefit

, 2025-05-07 12:17:00 TOPLINE: In a modeling analysis, initiating direct acting or nonvitamin K oral anticoagulants (DOAC/NOAC) in patients with device-detected subclinical atrial fibrillation (AF) provided a net gain of approximately 1 additional quality-adjusted week of life per patient over 10 years, equating to a 65.8% chance of treatment offering more benefits than withholding it….

Read More

Anticoagulation in Subclinical AF May Offer Little Benefit

, 2025-05-07 12:17:00 TOPLINE: In a modeling analysis, initiating direct acting or nonvitamin K oral anticoagulants (DOAC/NOAC) in patients with device-detected subclinical atrial fibrillation (AF) provided a net gain of approximately 1 additional quality-adjusted week of life per patient over 10 years, equating to a 65.8% chance of treatment offering more benefits than withholding it….

Read More

Coreline Soft’s lung cancer screening AI added to Bayer’s Calantic platform

, 2025-05-08 04:17:00 An AI-powered lung cancer screening analysis software by South Korean company Coreline Soft has been added to the medical AI platform of global pharmaceutical firm Bayer.  Its flagship product, AVIEW LCS, is now among the selections of medical imaging AI software offered in Bayer’s vendor-neutral, cloud-based marketplace, Calantic, along with similar solutions from fellow Korean…

Read More

How satisfaction with your partner’s looks directly boosts relationship quality

, 2025-05-08 03:27:00 Canadian researchers reveal how your view of your partner’s looks, and how you think they see you, can make or break relationship satisfaction. Mutual appreciation and reduced body criticism are key. Study: Satisfaction with partner’s appearance, body criticism, and relationship quality in heterosexual couples: A dyadic study. Image Credit: Prostock-studio / Shutterstock In a…

Read More

Over 1000 GP Surgeries to Receive Modernisation Funding

, 2025-05-07 12:17:00 More than 1000 GP surgeries across England will receive government funding to upgrade outdated premises and boost patient access, the Department of Health and Social Care (DHSC) has announced. The £102 million investment for 2025-2026 will be delivered through the Primary Care Utilisation and Modernisation Fund. The fund was announced during the…

Read More

How 4 Employers Are Supporting Workers Through Challenging Times

Marissa Plescia , 2025-05-08 00:24:00 Americans are facing difficult times, including rising healthcare costs and increasing prevalence of mental health challenges. And many are looking to their employer for support. That’s why during a Wednesday panel discussion at the Midwest Business Group on Health conference in Chicago, four employers shared the strategies they’ve implemented to…

Read More

Vinay Prasad’s FDA speech: Praises staff, embraces evidence

Lizzy Lawrence , 2025-05-08 02:15:00 WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his admiration for agency employees, and his desire to serve the American public.  The new director of the Center for Biologics Evaluation and Research sounded very different from his online firebrand persona….

Read More

Researchers secure funding to advance Chagas disease research

, 2025-05-08 02:08:00 A team of researchers at Texas A&M University and the University of Georgia (UGA) has received more than $4 million from federal and non-governmental organizations to support research on Chagas disease prevalence, diagnostics and treatment to benefit both dogs and humans. Chagas disease is a tropical illness caused by the parasite Trypanosoma cruzi,…

Read More

Measles Is Back: A Wake-Up Call

, 2025-05-07 12:34:00 Many still believe that measles is a harmless disease and that vaccinations are more harmful, citing autism as a potential side effect, a claim debunked by numerous studies, including a notable 2015 cohort study in the United States. Vaccine expert Peter Jay Hotez, MD, PhD, director of the Center for Vaccine Development…

Read More

Los Angeles declares hepatitis A outbreak

Stephen I. Feller , 2025-05-07 15:55:00 Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . ” data-action=subscribe> Subscribe We were unable to process your request. Please try again later. If you continue to have…

Read More

White House withdraws nomination of Janette Nesheiwat for U.S. surgeon general

Associated Press , 2025-05-07 20:57:00 WASHINGTON — The White House is withdrawing the nomination of former Fox News medical contributor Janette Nesheiwat for U.S. surgeon general, marking at least the second health-related pick from President Donald Trump to be pulled from Senate consideration. The withdrawal was confirmed by two people familiar with the matter. Nesheiwat had been scheduled to…

Read More

Radical vs. simple hysterectomy? Researcher says post-operative sexual health should be considered

, 2025-05-07 20:44:00 Credit: Unsplash/CC0 Public Domain For people with low-risk, early-stage cervical cancer, a simple hysterectomy removing the uterus and cervix has similar cancer outcomes to a more invasive radical hysterectomy—all while providing improved bladder function and sexual health. That’s the finding of a Toronto-led international research team led by Sarah Ferguson, a gynecologic…

Read More

Recognizing COPD as a Women’s Health Issue

, 2025-05-07 12:46:00 Over the next 25 years, the global prevalence of chronic obstructive pulmonary disease (COPD) is expected to grow by as much as 23%. Importantly, a majority of these cases are projected to occur in women. In the United States, an increased prevalence in women has also been reported. Why, then, is COPD…

Read More

New insights into oral cancer progression and treatment

, 2025-05-07 20:49:00 The potential mechanism after blocking LSD1 inhibits novel CDK7 phospho-protein networks and STAT3 signaling ultimately promotes CD8+ T cell infiltration and activation by relieving CTLA4-mediated immunosuppression. Credit: Chinese Academy of Sciences Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to improving patient outcomes. However,…

Read More

Ten-year data confirm exercise is a powerful tool against depression

, 2025-05-07 22:59:00 Study: A 10 years update of effects of exercise on depression disorders—In otherwise healthy adults: A systematic review of meta-analyses and neurobiological mechanisms. Image Credit: People-Images.com / Yuri A / Shutterstock.com A new PLoS ONE study provides an updated review on how exercise influences depression in otherwise healthy adults. How does physical activity…

Read More

Does Salvage Transplant Show Benefit?

, 2025-05-07 12:47:00 TOPLINE: After a median follow-up of 99 months, salvage high-dose chemotherapy and autologous stem cell transplantation (sHDCT/ASCT) showed no survival benefit compared with continuous lenalidomide/dexamethasone in relapsed multiple myeloma. The absence of benefit was consistent across all subgroups, including patients with time to progression after frontline transplant beyond 48 months. METHODOLOGY: Researchers…

Read More

Advanced molecular test can improve diagnosis of a genetic form of COPD

, 2025-05-07 21:11:00 Illustrations showing the 23 SERPINA1 single nucleotide polymorphisms (23-SNP AAT) assay design. Credit: CHEST Pulmonary (2024). DOI: 10.1016/j.chpulm.2024.100076 National Jewish Health researchers with the Advanced Diagnostic Laboratories have developed a molecular diagnostic test capable of accurately diagnosing a major genetic cause of chronic obstructive pulmonary disease (COPD) known as Alpha-1 Antitrypsin Deficiency…

Read More

Researchers trace origins of aggressive childhood brain tumors

, 2025-05-07 16:56:00 Medulloblastoma is one of the most common malignant tumors of the central nervous system (CNS) in children and adolescents. It develops in the area of the cerebellum, which is responsible for movement coordination, among other things. Medulloblastomas enlarge rapidly, often grow into surrounding tissue and can also form metastases. The wide variety…

Read More

Childhood Sunburns Linked to Future Melanoma Risk

, 2025-05-07 12:51:00 TOPLINE: In a large cohort study, each additional blistering sunburn before the age of 15 years increased melanoma risk by approximately 3%, and the associated risk was not modified by personal sun sensitivity factors, such as eye and hair color. METHODOLOGY: Researchers analyzed data from 44,021 cancer-free non-Hispanic White participants in the…

Read More

No, HHS are not creating an autism register

Joanna Mulvaney PhD , 2025-05-07 20:44:00 If you have been following health news in North America, you may have seen people discussing the US federal government’s Department of Health and Human Services plans to create a database of people who have autism. Understandably, the idea that a bunch of kooks and quacks led by admitted…

Read More

Former NIH director blasts Trump’s ‘devastating’ science cuts

Lev Facher , 2025-05-07 20:46:00 Francis Collins, the former director of the National Institutes of Health, excoriated the Trump administration’s efforts to upend federal scientific agencies on Wednesday, saying the logic behind the moves “escapes any possible explanation.”  Speaking on a panel about trust in science and scientific institutions, Collins also expressed a degree of…

Read More

The Struggle to Convince Vaccine-Skeptical Parents

, 2025-05-07 12:57:00 A two-part communication strategy that included discussing vaccine concerns with skeptical parents was not effective in boosting immunization among their children, according to a new study published in JAMA Network Open. Researchers tested the combined effects of two techniques to increase vaccine uptake — presumptive language and motivational interviewing — on around…

Read More

Moxidectin could provide a faster route to eliminating parasitic infection endemic to Africa

, 2025-05-07 19:14:00 Credit: Unsplash/CC0 Public Domain Tens of millions of people in Africa are infected by parasitic worms that cause lymphatic filariasis (also called elephantiasis), a disease that leads to severe swelling and deformities of the limbs and genitals. Despite widespread treatment programs that have successfully reduced the risk of contracting lymphatic filariasis, hundreds…

Read More

Teen drivers face higher risks in older vehicles

, 2025-05-07 17:51:00 Motor vehicle crashes are the leading cause of death for U.S. teens. Newer vehicles and driver assistance technologies show promise in reducing crashes and injury severities. Researchers at Nationwide Children’s Hospital reviewed national fatal crash data (2016-2021) and examined the vehicle age and driver assistance technologies of vehicles driven by teen and…

Read More

Long-Acting HIV Injectable Effective Regardless of Viremia

, 2025-05-07 13:05:00 TOPLINE: Long-acting antiretroviral therapy (LA-ART) maintained high viral suppression for 48 weeks in patients with HIV regardless of initial viremia. METHODOLOGY: Researchers examined viral suppression for 48 weeks following the initiation of LA-ART — a cabotegravir plus rilpivirine regimen — in patients with HIV comparing those with viremia (≥ 30 copies/mL of…

Read More
Advertise here
error: Content is protected !!